96 related items for PubMed ID: 8346593
1. [Angiotensin I converting enzyme inhibitor enalapril in treatment of progressive chronic nephropathy. An open randomized controlled trial].
Kamper AL, Strandgaard S, Leyssac PP.
Ugeskr Laeger; 1993 Aug 02; 155(31):2406-9. PubMed ID: 8346593
[Abstract] [Full Text] [Related]
2. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
Petersen LJ, Petersen JR, Talleruphuus U, Møller ML, Ladefoged SD, Mehlsen J, Jensen HA.
Clin Nephrol; 2001 May 02; 55(5):375-83. PubMed ID: 11393383
[Abstract] [Full Text] [Related]
3. [The effect of the angiotensin-converting enzyme inhibitor enalapril on the rates of progression of chronic kidney failure in patients with different degrees of functional kidney disorders].
Esaian AM, Kaiukov IG, Titova VA.
Ter Arkh; 1995 May 02; 67(6):57-9. PubMed ID: 7667785
[Abstract] [Full Text] [Related]
4. Late outcome of a controlled trial of enalapril treatment in progressive chronic renal failure. Hard end-points and influence of proteinuria.
Kamper AL, Strandgaard S, Leyssac PP.
Nephrol Dial Transplant; 1995 May 02; 10(7):1182-8. PubMed ID: 7478121
[Abstract] [Full Text] [Related]
5. Effect of enalapril on the progression of chronic renal failure. A randomized controlled trial.
Kamper AL, Strandgaard S, Leyssac PP.
Am J Hypertens; 1992 Jul 02; 5(7):423-30. PubMed ID: 1637513
[Abstract] [Full Text] [Related]
6. Angiotensin converting enzyme inhibitor and chronic renal failure.
Sitprija V, Lumlertgul D.
J Med Assoc Thai; 1993 Jul 02; 76(7):359-67. PubMed ID: 8089635
[Abstract] [Full Text] [Related]
7. Acute and long-term effects of ACE inhibition on renal haemodynamics in glomerular and interstitial nephropathies.
Guidi E, Minetti EE, Cozzi MG.
J Renin Angiotensin Aldosterone Syst; 2002 Mar 02; 3(1):40-5. PubMed ID: 11984747
[Abstract] [Full Text] [Related]
8. Proteinuria predicts end-stage renal failure in non-diabetic chronic nephropathies. The "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN).
Ruggenenti P, Perna A, Mosconi L, Matalone M, Pisoni R, Gaspari F, Remuzzi G.
Kidney Int Suppl; 1997 Dec 02; 63():S54-7. PubMed ID: 9407422
[Abstract] [Full Text] [Related]
9. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
Esnault VL, Brown EA, Apetrei E, Bagon J, Calvo C, DeChatel R, Holdaas H, Krcmery S, Kobalava Z, Amlodipine Versus Enalapril in Renal failure (AVER) Study Group.
Clin Ther; 2008 Mar 02; 30(3):482-98. PubMed ID: 18405787
[Abstract] [Full Text] [Related]
10. Initial effect of enalapril on kidney function in patients with moderate to severe chronic nephropathy.
Kamper AL, Thomsen HS, Nielsen SL, Strandgaard S.
Scand J Urol Nephrol; 1990 Mar 02; 24(1):69-73. PubMed ID: 2157277
[Abstract] [Full Text] [Related]
11. [The effect of angiotensin-converting enzyme inhibitors on left ventricular hypertrophy in patients with chronic glomerulonephritis and pronounced kidney failure].
Diadyk AI, Bagriĭ AE, Lebed' IA, Iarovaia NF, Shchukina EV, Gaĭdukov VO, Gritsenko PV, Diadyk IA.
Ter Arkh; 1997 Mar 02; 69(6):24-7. PubMed ID: 9297267
[Abstract] [Full Text] [Related]
12. Are angiotensin converting enzyme inhibitors superior to beta blockers in retarding progressive renal function decline?
van Essen GG, Apperloo AJ, Rensma PL, Stegeman CA, Sluiter WJ, de Zeeuw D, de Jong PE.
Kidney Int Suppl; 1997 Dec 02; 63():S58-62. PubMed ID: 9407423
[Abstract] [Full Text] [Related]
13. Long-term enalapril treatment in diabetic nephropathy.
Mulec H, Johnsen SA, Björck S.
Kidney Int Suppl; 1994 Feb 02; 45():S141-4. PubMed ID: 8158883
[Abstract] [Full Text] [Related]
14. Comparison of the effects of an angiotensin converting enzyme inhibitor and a calcium antagonist in hypertensive, macroproteinuric diabetic patients: a randomised double-blind study.
O'Donnell MJ, Rowe BR, Lawson N, Horton A, Gyde OH, Barnett AH.
J Hum Hypertens; 1993 Aug 02; 7(4):333-9. PubMed ID: 8410924
[Abstract] [Full Text] [Related]
15. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.
Estacio RO, Jeffers BW, Gifford N, Schrier RW.
Diabetes Care; 2000 Apr 02; 23 Suppl 2():B54-64. PubMed ID: 10860192
[Abstract] [Full Text] [Related]
16. The influence of angiotensin-converting enzyme inhibition on renal tubular function in progressive chronic nephropathy.
Kamper AL, Holstein-Rathlou NH, Leyssac PP, Strandgaard S.
Am J Kidney Dis; 1996 Dec 02; 28(6):822-31. PubMed ID: 8957033
[Abstract] [Full Text] [Related]
17. Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.
Jerums G, Allen TJ, Campbell DJ, Cooper ME, Gilbert RE, Hammond JJ, O'Brien RC, Raffaele J, Tsalamandris C, Melbourne Diabetic Nephropathy Study Group.
Diabet Med; 2004 Nov 02; 21(11):1192-9. PubMed ID: 15498085
[Abstract] [Full Text] [Related]
18. Enalapril dosage in progressive chronic nephropathy: a randomised, controlled trial.
Elung-Jensen T, Heisterberg J, Sonne J, Strandgaard S, Kamper AL.
Eur J Clin Pharmacol; 2005 Apr 02; 61(2):87-96. PubMed ID: 15761754
[Abstract] [Full Text] [Related]
19. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.
Ravid M, Lang R, Rachmani R, Lishner M.
Arch Intern Med; 1996 Feb 12; 156(3):286-9. PubMed ID: 8572838
[Abstract] [Full Text] [Related]
20. Kidney function after withdrawal of long-term antihypertensive treatment in diabetic nephropathy.
Hansen HP, Nielsen FS, Rossing P, Jacobsen P, Jensen BR, Parving HH.
Kidney Int Suppl; 1997 Dec 12; 63():S49-53. PubMed ID: 9407421
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
